$8.310
-0.084 (-1.01%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CTNM Prediction & Forecast by Similar Chart Analysis
Alphio's CTNM stock price prediction model matches the current Contineum Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.59 (+3.41%). The 1-week path is $8.19 (-1.40%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Contineum Therapeutics Inc Stock?
Contineum Therapeutics Inc (CTNM) is currently not a strong buy due to recent negative catalysts, including a failed clinical trial that has impacted investor confidence. The stock is trading at $8.31, significantly below its 52-week high of $17.78, reflecting a 53% drop from that peak. Additionally, the RSI is at 36.49, indicating that the stock is nearing oversold territory but still lacks strong momentum for a rebound. The company has a forward P/E of 0, suggesting uncertainty in future earnings, and while it has a solid cash position of $236.6 million, the recent trial failure raises concerns about the viability of its key drug pipeline.
CTNM stock price ended at $8.31 on Friday, after losing -1.01%
Contineum Therapeutics Inc (CTNM) last closed at $8.31, losing -1.01%. These facts feed the 1-day and 1-week CTNM price prediction above.
Forecast Drivers
Contineum Therapeutics Inc (CTNM) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CTNM, ranked by similarity.
Seasonality analysis for CTNM
Historically the probability of a positive October return for CTNM is 47.62%. August offers the highest probability of a positive month at 67.19%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CTNM
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $3.06 | $3.88 | $4.41 | -53.28% |
| Nov 2026 | $3.08 | $3.92 | $3.98 | -52.88% |
| Dec 2026 | $3.75 | $4.57 | $4.88 | -45.03% |
In 2026, Contineum Therapeutics Inc (CTNM) is projected to range from $3.06 to $4.88.
Contineum Therapeutics Inc 2026 monthly forecast
In Oct 2026, Contineum Therapeutics Inc is projected to average $3.88, with a low of $3.06 and high of $4.41.
In Nov 2026, Contineum Therapeutics Inc is projected to average $3.92, with a low of $3.08 and high of $3.98.
In Dec 2026, Contineum Therapeutics Inc is projected to average $4.57, with a low of $3.75 and high of $4.88.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.